Session submissions 3Rs Integrating 3 Worlds: Human, Animal and Environmental Health

Be the catalyst of change and shape tomorrow’s future with your contribution! Present groundbreaking research, showcase visionary projects, and drive dynamic discussions in the Scientific Program of the Congress.

Up to

800+ .......... 50+ .......... 30+
Participants Expected Program Sessions       Sponsors

List of Accepted Sessions

Below, you will find the full list of accepted sessions for the 13th World Congress in Rio. With a diverse and dynamic program, we are excited to present a wide range of sessions covering key topics and emerging trends in the field.

Due to space limitations, some excellent proposals could not be accommodated, but we appreciate all submissions and the enthusiasm of our global community.

Please note that session numbers are provisional and may change in the final program. Stay tuned for updates as we approach the event!

Animal Health

Session #26: One world, many standards: international perspectives on regulating the use of animals in science
Session #55: 3Rs Implementation in Brazil: a Successful Multi-stakeholder Joint Effort
Session #56: Working together to end ‘severe’ suffering
Session #60: How systematic reviews and meta-analyses support good animal welfare and the transition to animal-free research
Session #74: Bias, Reporting and Assessment – How to replace, reduce and refine animal experiments by looking at the available data
Session #94: Fishing for the 3Rs? Why using fish should not count as refinement and their suffering does matter.
Session #99: Phase out of animal testing in veterinary vaccines batch release test - An overview of Multi-stakeholders efforts
Session #118: Ethics in Action: Upholding the 3Rs through Animal Research Ethical Review

Environmental Health

Session #40: Environmental safety assessment of chemicals– Progress of different animal-free tools, similarities and differences with human safety assessments
Session #42: Complex chemical exposure– How can in vitro bioassays improve current practice in human biomonitoring and environmental monitoring?
Session #61: Humans are Model Organisms Too: Opportunities for Synergistic, Data-Driven Enhancement Across Human and Environmental Safety Assessment
Session #63: Marine Environmental Safety: recent advances in NAMs to evaluate toxicity of chemicals of emerging concern in marine environments
Session #107: Accelerating Science to Policy Transfer of Animal Alternatives for human and Environmental safety assessment: lessons learned and ways forward
Session #138: Moving forward towards the application of New Approach methodologies for the environmental risk assessment of chemicals
Session #137: NAMs to Assess the Properties of Chemical Mixtures for Environmental Health

Education

Session #32: “Eye-opening” education for experimenters
Session #39: “Alternative Models for Surgical Training”
Session #43: Hands-on Training in Aspects of NAMs improves the translational value
Session #54: Empowering the Next Generation of Researchers for Next Generation Risk Assessment
Session #71: Integrating all 3Rs at Research Institutions through Training, Education, and Culture
Session #81: Breaking Down Silos to Achieve One Health - Integrating Environment into Education and Training Initiatives in Latin America and Beyond
Session #122: Building an Ethical and Innovative Career: Guidance for Biology, Veterinary, and Medical Students and Professionals
Session #144: Empowering Change through Informal Education: Leveraging Workshops and Webinars to Promote the 3Rs

One health / Harmonisation / Technologies

Session #4: 3Rs in space: animal-free alternatives for life sciences in space research
Session #9: Current and Future Directions for Human and Environmental Exposure Assessment in Next Generation Risk Assessment: From External to Internal Approaches Across Regulatory Silos
Session #30: Global Harmonization in Risk Assessment: Navigating the Complexities of Animal Testing, Regulatory Divergence, and Environmental Sustainability
Session #36: Leveraging inter-disciplinary and human-relevant approaches to address mental health
Session #41: NAMs as tools to operationalize One Health in human toxicology and ecotoxicology
Session #78: Unveiling Chemical Similarity in Computational Toxicology: Navigating Supervised and Unsupervised Approaches
Session #132: Application of New Approach Methods in the Safe and Sustainable Design of Innovative Products
Session #126: One Health, Many Models: Computational Approaches for Systemic Toxicities

Human Health - Reduction, Refinement, Other

Session #5: Proposing Sentience as a Heuristic Device for Selecting Animal Models in Scientific Research
Session #33: Generative AI for Drug Safety and Toxicology
Session #53: Challenges in Asia to adopting the 3Rs across areas of animal use
Session #62: One science: The Continuum of New Approach Methodologies from research to regulation
Session #92: Integrated strategy for DART New Approach Methods
Session #134: Exposure-based human risk assessment to minimize unnecessary animal testing for agrochemicals
Session #117: The 5Rs of Developmental Immunotoxicity Testing: Advancing Ethical and Predictive Methods

Human Health - Policy

Session #15: Regulatory experience using a weight of evidence approach to reducing testing on animals
Session #29: Building Confidence and Transparency into Validation Management and Peer Review
Session #48: Confidence in in vitro alternatives to animal testing - defining standards to ensure rigorous and reproducible data
Session #67: Regulatory Acceptance of Alternatives to Animal Testing by Anvisa
Session #75: Update to OECD Guidance Document 34 on the validation of test methods and Defined Approaches
Session #84: Transitioning to Animal-Free Chemical Safety Assessment
Session #98: Transitioning away from animal testing for vaccine quality control testing: international and regional perspectives
Session #109: From internal decision making to regulatory approval: Finding strategies to accelerate the use of NAMs
Session #106: The bigger picture of NAM uptake: exploring psychological and system factors as promoters and inhibitors
Session #113: Overcoming barriers to regulatory uptake of Next Generation Risk Assessment
Session #125: Ending 100 years of suffering: Regulatory assessment of Acute Oral Toxicity without using animals
Session #127: Regulatory Frameworks for Complex Endpoints
Session #133: Advancing Chemical Risk Assessment with Microphysiological Systems (MPS): Current Innovations and Potential for Regulatory Translation
Session #143: Sailing the Seas of Validation: Challenges Encountered to Chart the Course Ahead

Human Health - Replacement

Session #13: The journey towards animal-free systemic toxicity assessment for cosmetics
Session #17: Session on Current Research Initiatives on NAMs in Korea and Global Cooperation for Regulatory Application
Session #20: Artificial Intelligence to reduce and replace animal testing
Session #22: Implementation of NAM based PBK modelling into regulatory hazard assessment
Session #24: New Approach Methodologies (NAMs) for Assessing Reproductive and Developmental Toxicity
Session #25: 3D Bioprinting Put Towards Tissue Model Fabrication
Session #44: Advanced Strategies for Implementation of the 3R Principles in Genotoxicity Assessment
Session #46: Reflecting Human Diversity with In Vitro Models
Session #64: Accelerating regulatory acceptance of complex manufactured and natural products through New Approach Methodologies (NAMs)
Session #69: Replacing invisible animal suffering – Animal-free materials in cell and tissue culture
Session #77: Development of non-animal methods for the identification of respiratory sensitizers: Reconciling the differences in clinical diagnosis and regulatory policies
Session #79: Using New Approach Methods (NAMs) to derive point-of-departures (PoD) for Next Generation Risk Assessment (NGRA) of skin sensitizers: towards regulatory implementation.
Session #100: Animal Replacement Technologies Down Under - Unifying Science, Innovation, and Humanity for a Sustainable Future.
Session #101: Formulating a framework for non-animal safety assessment of human pharmaceuticals
Session #102: The Future is Now: The Power of NAMs for a global acceptance for Local Tolerance
Session #103: ASPA, the guided workflow for next-generation chemical safety assessment
Session #135: Next-Generation Risk Assessment (NGRA)
Session #136: Safety by Design: A Global Framework for Pharmaceutical Development